Technical Articles
UA085067
P53 in Biopharma: From a 40-Year Drug Hunt to Reagent Standardization
Why P53 has driven four decades of drug discovery yet remains unsolved, and how standardized recombinant P53 reagents support target validation, screening and mechanistic studies across the industry.
View details
- Cancer
- P53
- TP53 drug discovery
- targeted therapy
- PROTAC
- reagent standardization
- UA085067
P53 Research Reagents: How to Choose and Use Recombinant P53 Protein
A practical guide to recombinant P53 protein as a research reagent: tag format, purification, activity validation, and how to design DNA-binding, reporter and mutant-comparison experiments around P53.
View details
- Cancer
- P53 protein
- recombinant P53
- His tag
- DNA-binding assay
- reporter assay
- mutant control
- UA085067
P53: Guardian of the Genome and a Persistent Challenge in Cancer Therapy
P53 (TP53) is the most studied tumor suppressor. This article breaks down its domain architecture, stress-activation mechanism, hotspot mutation spectrum, and the functional readouts and experimental interfaces commonly used in tumor research.
View details
- Cancer
- P53
- TP53
- tumor suppressor
- DNA damage
- DNA-binding domain
- hotspot mutation
- MDM2
- apoptosis
- UA085067
- 1









